The new article provides additional details regarding the regulatory requirements for the importation of investigational products, as well as other aspects. Table of Contents The Drug Regulatory Authority of Pakistan (DRAP),...
The new article describes in detail certain specific aspects related to post-market surveillance – in particular, the way the authority is going to communicate important safety-related information to stakeholders. Table of...
The new article describes in detail the procedure to be followed when applying for permission to conduct clinical trials in Pakistan. Table of Contents The Drug Regulatory Authority of Pakistan (DRAP), a country’s regulatory...
The new article describes in detail the regulatory requirements related to reporting incidents with medical devices and other healthcare products. Table of Contents The Ministry of Health of Kenya, Pharmacy and Poisons Board, has...
The article provides an overview of Pakistan’s regulatory framework for clinical trials and applications to be submitted by interested parties. Table of Contents The Drug Regulatory Authority of Pakistan (DRAP), a country’s...